N-{3-[4-(Dimethylamino)benzenesulfonamido]-phenyl}-2-[(4-oxo-4H-chromen-7-yl)oxy]acetamide

ID: ALA4474271

PubChem CID: 155536890

Max Phase: Preclinical

Molecular Formula: C25H23N3O6S

Molecular Weight: 493.54

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CN(C)c1ccc(S(=O)(=O)Nc2cccc(NC(=O)COc3ccc4c(=O)ccoc4c3)c2)cc1

Standard InChI:  InChI=1S/C25H23N3O6S/c1-28(2)19-6-9-21(10-7-19)35(31,32)27-18-5-3-4-17(14-18)26-25(30)16-34-20-8-11-22-23(29)12-13-33-24(22)15-20/h3-15,27H,16H2,1-2H3,(H,26,30)

Standard InChI Key:  HGAFJBXQTDAANX-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 35 38  0  0  0  0  0  0  0  0999 V2000
    6.9049  -16.1954    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.4984  -15.4855    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    6.0897  -16.1954    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.7904  -15.0778    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0821  -15.4852    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3734  -15.0784    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3734  -14.2586    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0795  -13.8477    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.7904  -14.2533    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6654  -13.8510    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.9573  -14.2586    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6654  -13.0314    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.2065  -15.0778    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.9187  -15.4855    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.9187  -16.3096    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.6293  -16.7150    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.3350  -16.3043    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.3350  -15.4849    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.0431  -15.0773    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   10.7512  -15.4849    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.7512  -16.3043    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   11.4592  -15.0773    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.1673  -15.4849    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   12.8795  -15.0773    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.5877  -15.4874    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.2960  -15.0742    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.0043  -15.4812    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   15.7062  -15.0704    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.7062  -14.2568    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.9998  -13.8498    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.9998  -13.0303    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   14.2960  -14.2606    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.5853  -13.8486    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.8795  -14.2577    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.6267  -15.0783    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  2  0
  2  3  2  0
  2  4  1  0
  5  4  2  0
  6  5  1  0
  7  6  2  0
  8  7  1  0
  9  8  2  0
  4  9  1  0
  7 10  1  0
 10 11  1  0
 10 12  1  0
 13  2  1  0
 14 13  1  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  1  0
 20 21  2  0
 20 22  1  0
 22 23  1  0
 23 24  1  0
 24 25  1  0
 25 26  2  0
 26 27  1  0
 27 28  1  0
 28 29  2  0
 29 30  1  0
 30 31  2  0
 32 30  1  0
 26 32  1  0
 32 33  2  0
 33 34  1  0
 34 24  2  0
 18 35  1  0
 35 14  2  0
M  END

Alternative Forms

  1. Parent:

    ALA4474271

    ---

Associated Targets(Human)

ROCK1 Tclin Rho-associated protein kinase 1 (4723 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ROCK2 Tclin Rho-associated protein kinase 2 (6206 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 493.54Molecular Weight (Monoisotopic): 493.1308AlogP: 3.68#Rotatable Bonds: 8
Polar Surface Area: 117.95Molecular Species: NEUTRALHBA: 7HBD: 2
#RO5 Violations: HBA (Lipinski): 9HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 8.32CX Basic pKa: 2.38CX LogP: 3.02CX LogD: 2.98
Aromatic Rings: 4Heavy Atoms: 35QED Weighted: 0.38Np Likeness Score: -1.39

References

1. Zhao L, Li Y, Wang Y, Qiao Z, Miao Z, Yang J, Huang L, Tian C, Li L, Chen D, Yang S..  (2019)  Discovery of 4H-Chromen-4-one Derivatives as a New Class of Selective Rho Kinase (ROCK) Inhibitors, which Showed Potent Activity in ex Vivo Diabetic Retinopathy Models.,  62  (23): [PMID:31693351] [10.1021/acs.jmedchem.9b01143]

Source